Integral Ad Science (NASDAQ:IAS) Given Hold Rating at Benchmark

Benchmark reiterated their hold rating on shares of Integral Ad Science (NASDAQ:IASFree Report) in a research report sent to investors on Tuesday morning, Benzinga reports.

Several other equities research analysts also recently issued reports on the company. Loop Capital began coverage on Integral Ad Science in a report on Tuesday, April 30th. They set a buy rating and a $15.00 price objective on the stock. Piper Sandler reduced their price objective on shares of Integral Ad Science from $20.00 to $18.00 and set an overweight rating on the stock in a research note on Wednesday, February 28th. Bank of America initiated coverage on shares of Integral Ad Science in a research report on Thursday, January 11th. They issued a buy rating and a $19.00 target price for the company. BMO Capital Markets decreased their price target on Integral Ad Science from $18.00 to $16.00 and set an outperform rating for the company in a research note on Wednesday, February 28th. Finally, Barclays cut their price objective on Integral Ad Science from $16.00 to $12.00 and set an equal weight rating on the stock in a research note on Monday, April 15th. Three equities research analysts have rated the stock with a hold rating and ten have given a buy rating to the company’s stock. According to MarketBeat, Integral Ad Science presently has a consensus rating of Moderate Buy and a consensus target price of $17.38.

Get Our Latest Stock Report on Integral Ad Science

Integral Ad Science Stock Down 0.7 %

Shares of NASDAQ:IAS opened at $9.90 on Tuesday. The company has a 50 day moving average of $9.85 and a two-hundred day moving average of $12.85. Integral Ad Science has a 52-week low of $8.92 and a 52-week high of $20.88. The company has a quick ratio of 3.21, a current ratio of 3.21 and a debt-to-equity ratio of 0.17. The company has a market capitalization of $1.58 billion, a price-to-earnings ratio of 248.81, a price-to-earnings-growth ratio of 1.72 and a beta of 1.58.

Integral Ad Science (NASDAQ:IASGet Free Report) last released its quarterly earnings results on Tuesday, February 27th. The company reported $0.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.03 by $0.03. The firm had revenue of $134.30 million for the quarter, compared to the consensus estimate of $131.27 million. Integral Ad Science had a net margin of 1.53% and a return on equity of 0.83%. The firm’s quarterly revenue was up 14.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.07 EPS. As a group, analysts forecast that Integral Ad Science will post 0.16 earnings per share for the current fiscal year.

Insider Buying and Selling at Integral Ad Science

In other news, CEO Lisa Utzschneider sold 8,044 shares of the company’s stock in a transaction dated Monday, May 6th. The shares were sold at an average price of $9.97, for a total transaction of $80,198.68. Following the completion of the transaction, the chief executive officer now owns 203,139 shares in the company, valued at $2,025,295.83. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other Integral Ad Science news, CEO Lisa Utzschneider sold 8,044 shares of Integral Ad Science stock in a transaction on Monday, May 6th. The stock was sold at an average price of $9.97, for a total transaction of $80,198.68. Following the sale, the chief executive officer now owns 203,139 shares of the company’s stock, valued at approximately $2,025,295.83. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Tania Secor sold 17,999 shares of the business’s stock in a transaction on Monday, April 8th. The stock was sold at an average price of $10.05, for a total value of $180,889.95. Following the transaction, the chief financial officer now owns 239,174 shares of the company’s stock, valued at approximately $2,403,698.70. The disclosure for this sale can be found here. Over the last three months, insiders have sold 75,126 shares of company stock worth $749,707. 2.00% of the stock is owned by insiders.

Institutional Investors Weigh In On Integral Ad Science

Several hedge funds and other institutional investors have recently added to or reduced their stakes in IAS. Goldman Sachs Group Inc. raised its stake in shares of Integral Ad Science by 605.1% in the 4th quarter. Goldman Sachs Group Inc. now owns 2,740,011 shares of the company’s stock worth $39,429,000 after buying an additional 2,351,414 shares in the last quarter. abrdn plc bought a new position in shares of Integral Ad Science during the 4th quarter valued at about $25,285,000. Vanguard Group Inc. grew its stake in shares of Integral Ad Science by 15.2% in the 3rd quarter. Vanguard Group Inc. now owns 7,325,778 shares of the company’s stock worth $87,104,000 after purchasing an additional 966,280 shares during the last quarter. P2 Capital Partners LLC bought a new stake in shares of Integral Ad Science in the 4th quarter worth approximately $11,144,000. Finally, TimesSquare Capital Management LLC lifted its stake in Integral Ad Science by 32.2% during the third quarter. TimesSquare Capital Management LLC now owns 2,486,748 shares of the company’s stock valued at $29,567,000 after purchasing an additional 605,824 shares during the last quarter. Institutional investors own 95.78% of the company’s stock.

About Integral Ad Science

(Get Free Report)

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.

Read More

Analyst Recommendations for Integral Ad Science (NASDAQ:IAS)

Receive News & Ratings for Integral Ad Science Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integral Ad Science and related companies with MarketBeat.com's FREE daily email newsletter.